Selection and Characterization of FD164, a High-Affinity Signal Regulatory Protein α Variant with Balanced Safety and Effectiveness, from a Targeted Epitope Mammalian Cell-Displayed Antibody Library-Reference-Cited by-同舟云学术

Selection and Characterization of FD164, a High-Affinity Signal Regulatory Protein α Variant with Balanced Safety and Effectiveness, from a Targeted Epitope Mammalian Cell-Displayed Antibody Library

Published:2021-07-27 Issue:3 Volume:100 Page:193-202
ISSN:0026-895X
Container-title:Molecular Pharmacology
language:en
Short-container-title:Mol Pharmacol

Author:

Wang Zhihong,Hu Naijing,Li Xinying,Wang Haitao,Ren Caiping,Qiao Chunxia,Chen Guojiang,Wang Jing,Zhou Liuzhong,Wu Jiaguo,Zhang Dingmu,Feng Jiannan,Shen Beifen,Peng Hui,Luo Longlong

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference40 articles.

1. CD47 Blockade by Hu5F9-G4 and Rituximab in Non-Hodgkin’s Lymphoma

2. Immunotherapy: cancer vaccines on the move;Banchereau;Nat Rev Clin Oncol,2018

3. The SIRP family of receptors and immune regulation

4. CD47 overexpression is associated with decreased neutrophil apoptosis/phagocytosis and poor prognosis in non-small-cell lung cancer patients

5. Tumor-associated macrophages and anti-tumor therapies: complex links

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Modulating macrophage-mediated programmed cell removal: An attractive strategy for cancer therapy;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2024-09

2. High-affinity decoy protein, nFD164, with an inactive Fc region as a potential therapeutic drug targeting CD47;Biomedicine & Pharmacotherapy;2023-06

3. Anti-Claudin18.2-IL-21 fusion protein bifunctional molecule has more powerful anti-tumor effect and better safety;International Immunopharmacology;2023-02

4. Structure-guided affinity maturation of a novel human antibody targeting the SARS-CoV-2 nucleocapsid protein;Scientific Reports;2022-05-19